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CAN ANTIBIOTIC USE IN PORK PRODUCTION REDUCE
CONSUMER RISK? 
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Iowa State University, Ames, Iowa, USA, 50010, 515-294-7905, shurd@iastate.edu, 
The risk of antibiotic use in food animals for purposes other that disease treatment is receiving
renewed scrutiny. In the U.S. the question is being addressed with qualitative and quantitative risk
assessments, in Scandinavia it has been addressed with prohibitions on the uses labeled as
growth promotion (Cox and Popken, 2004, Hurd, et al., 2004, US, FDA, 2002). However, every
risk assessment is likely to calculate some level of risk, albeit extremely low. Society and regula-
tors are not generally willing to permit or accept additional risk, unless there is some benefit. Is it
possible that this perceived “risky activity” of food animal antibiotic use could decrease con-
sumer risk? What if it reduced the burden of human illness associated with meat-borne bacteria
such as Salmonella or Campylobacter? What if healthier animals resulted in healthier meat, milk
and eggs? Clearly, society has a longstanding belief in the benefits of consuming healthy animals,
demonstrated in meat hygiene inspection rules dating back to1914 in the U.S. 
How could the use of antibiotics decrease Salmonella and Campylobacter rates on carcasses
and meat, thereby decreasing human risk? Risk is all about probabilities and dose; the probability
of an event happening and the exposure dose if it does. Figure 1 shows the key processes that
affect the probability and dose of Salmonella contamination in pork processing.
Figure 1 shows the many processes where the probability of contamination and dose can be
impacted by animal health. For example, chronic stress of disease will increase the likelihood and
degree of animal infection with pathogens such as Salmonella; disease control reduces risk.
Additionally, animal health likely influences slaughter and evisceration quality; processes that
affect the probability and amount of fecal contamination. Conditions that may increase the proba-
bility or amount of fecal contamination include: 
< peritonitis (inflammation of the abdominal area)
< pleuritis (inflammation of the chest area)
< adhesions (“scar tissue” connecting viscera to the interior of body cavity)
< amount and fluidity of gut contents (increase probability of tears or spills)
< gut friability (increase probability of tears or spills)
< airsacculitis (inflammation and adhesions in the chest area of poultry)
< any health condition that leads to extra handling for trimming e.g. skin lesions, 
abscesses, arthritis
Meat inspectors will notice many of these issues and remove obviously unwholesome product;
however, pathogens are invisible. The resulting feces from a gut spill are quickly cleaned up, but
the unseen bacteria on hands, machinery or tools are not so easily detected. The extra handling
required to trim contaminated surfaces or remove an arthritic joint has been shown to decrease
shelf life due to extra bacterial load. Inflammation of the airsacs in a poultry flock has been associ-
ated with increased Salmonella and Campylobacter loads (Russel, 2003). Antibiotic free pigs tend
to have more fluid gut contents. Any of these conditions may increase the probability and dose of
pathogen contamination.
Many animal diseases produce the types of conditions just described. These diseases include E.
coli infection (airsacculitis) and Clostridium perfringens infection producing necrotic enteritis in poul-
try. Pleuritis is common due to porcine respiratory disease of various bacterial causes at an early
age. Inflammation of the small intestine in swine (ileitis) may increase gut friability. Liver abscesses
in cattle and infectious arthritis in all animals lead to extra handling for trimming of unwholesome tis-
sue. 
Antibiotic use reduces or eliminates these diseases. Treatment with virginiamycin is effective
in preventing necrotic enteritis in poultry. Prevention of porcine respiratory disease at an early age
will avoid lesions such as chronic pleuritis or peritonitis and the resulting adhesions affecting evis-
ceration quality. Lastly, uses labeled for improved performance have been shown to actually
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reduce infections with Clostridium perfringens (Stutz and Lawton, 1984). Additionally, when
avoparcin was removed from Norwegian poultry, necrotic enteritis reached “epidemic propor-
tions” (Kaldhudsal, 2000). The loss of “growth promotion” antibiotics in all phases of Danish
swine production (1999) has been followed by a 100% increase in the use of antibiotics labeled
for treatment. To this point, there has been no decrease in Salmonella or Campylobacter illness or
resistance levels in humans.
Could these disease-related conditions really affect public health? Based on available data the
answer is “yes”. A simple calculation will demonstrate. A more sophisticated analysis for poultry
was presented recently (Singer, et al. 2005, http://www.ahc.umn.edu/news/releases/chick-
ens110204/). Say a pork processing plant, using antibiotic treated pigs, has about 5% of its carcass-
es Salmonella positive in the cooler. A large plant (15,000 head/day) would produce 750 Salmonella
positive carcasses per day. But some research, based on quantification of Salmonella loads, shows
that only about 4% of the resulting servings will be potentially infectious; computing to about
25,000 potentially infectious servings per day (Assumes: 110kg carcass weight, 20% of contami-
nated carcass is ground and potentially contaminated, 250g serving size) (Alban et al., 2002). 
If antibiotic free pigs are used and if they have slightly more disease which increases the
Salmonella carcass positive rate only two percentage points
to 7%, that plant is now producing 1,050 Salmonella positive
carcasses per day; a 40% increase. Additionally, if the dose
on those positive carcasses is increased two points so that
6% of the resulting servings will be potentially infectious,
then the number of potentially infectious servings sold per
day increases to 55,000; a 115% increase over the antibiotic
treated pigs. 
These calculations are based on the assumption that ani-
mal health conditions do impact the probability and dose of
final product contamination. More data are needed on this
topic, especially in cattle and swine. These types of studies
should be fairly easy to conduct. It is useful, but not neces-
sary that antibiotic free animals be used in these studies, as
the key hypothesis is the relationship between conditions
such as pleuritis, arthritis, etc. and carcass contamination with
microbial load. Until these studies can prove there is no con-
nection between animal health and pathogen load, we must
assume that removal of antibiotics in food production would
increase the human risk of generic Salmonella,
Campylobacter, and Yersinia infection more than it would
decrease risk from resistance.
Conclusion A quantitative risk assessment of the impact on
human health relative to the continued use of virginiamycin
has also been concluded. The report determined that the
quantitative human health risk from continued use of virgini-
amycin in the U.S. is less than one statistical life saved in the
entire U.S. population over the next 15 years (Cox and
Popken, 2004). Consistent with the Cox/Popken study, the
Food & Drug Administration in the U.S. draft risk assessment
of virginiamycin, demonstrated a risk of virginiamycin use in
the range of 0.7 to 14 chances in 100 million (US, FDA, 2004).
Additionally, work by this author shows the risk of any
adverse human effects (e.g. extra days of illness) of macrolide
use in poultry, pork and beef cattle was less than 10 in 100 million
per human year (Hurd et al., 2004). 
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Figure 1. Processes affecting the
probability and dose of Salmonella
contamination of wholesale pork
products resulting in potentially
infectious servings.
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Risk managers must compare the hypothetical risk of increased resistance to the thousands of
excess Campylobacter and Salmonella cases expected if medicated feed additives were banned.
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